ITRM vs PODD · rev $390.0K vs P/E 34, rev $2.07B
Iterum Therapeutics PLC (ITRM) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
ITRM currently screens at market cap $38.6M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the ITRM and PODD stock pages for the full models.
Not investment advice.